Skip to main content
Orchid

Whole-genome embryo screening · IVF

The most comprehensive genetic test available for IVF embryos.

Orchid is the only lab using whole-genome sequencing on embryo biopsies, detecting disease risks standard PGT-A consistently misses.

Orchid

Whole-genome screening

>99%

Standard PGT-A

Traditional embryo screening

<1%

Coverage of an embryo's genome · Source: Orchid validation studies

1,700+ conditions in one cycle

Clinically validated technology

Same biopsy as traditional PGT-A

Enter a 10-digit US phone number in the format (555) 123-4567.

By submitting, you agree to be contacted by Orchid. We never share your info. You can opt out any time.

Enter a 10-digit US phone number in the format (555) 123-4567.

By submitting, you agree to be contacted by Orchid. We never share your info. You can opt out any time.

As seen in

As seen in Arena Magazine
As seen in Freethink
As seen in GQ
As seen in The New York Times
As seen in The Boston Globe
As seen in The Information
As seen in The New Yorker
As seen in The Times
As seen in Wired
As seen in The Wall Street Journal
As seen in CNBC
As seen in Business Insider
As seen in Arena Magazine
As seen in Freethink
As seen in GQ
As seen in The New York Times
As seen in The Boston Globe
As seen in The Information
As seen in The New Yorker
As seen in The Times
As seen in Wired
As seen in The Wall Street Journal
As seen in CNBC
As seen in Business Insider

The big idea

More data. Better answers.

Most embryo tests look at less than 1% of the genome. Orchid sequences more than 99%. That's a meaningful difference, even without the technical details.

>99%

Orchid · Whole genome

Covers far more conditions

<1%

Standard PGT-A

Chromosomes only

At a glance.

Four things to know about embryo genetic testing, before you go deeper.

🧬

It's done during IVF.

Uses the standard embryo biopsy: a few cells from the outside of each embryo, sent to the lab.

📋

Screens for what matters most.

Genetic forms of neurodevelopmental conditions, hereditary cancer syndromes, and birth defects.

Results ready in 4 weeks.

Same turnaround as standard PGT testing. No added wait time for your cycle.

💬

Genetic counseling included.

Complimentary sessions with a genetic counselor, before testing and after results.

1 in 8

U.S. couples · trying to conceive

Many will use IVF and face genetic-testing decisions.

Source: RESOLVE / CDC NSFG
~50%

Embryos with chromosomal abnormalities

In women 35+, the share rises sharply with age.

Source: ASRM 2024 PGT-A Committee Opinion
1,700+

Conditions Orchid screens for

Across monogenic, structural, and polygenic risk.

Source: Orchid gene list

The four kinds

The four kinds of embryo tests.

Each looks for something different. Orchid combines all of them in a single whole-genome workflow.

PGT-A

Aneuploidy

Screens for an unexpected number of chromosomes such as Down syndrome, Trisomy 18, etc.

~1% of genome

PGT-M

Monogenic

Targets one known condition at a time (e.g. Cystic Fibrosis, Spinal Muscular Atrophy).

single gene per test

PGT-SR

Structural

Detects translocations & large rearrangements.

structural-only

Orchid
WGS

Whole genome

All four above + thousands of conditions + polygenic risk in one report.

>99% of genome

How it fits into your IVF cycle.

No extra cycle. No new clinic. Same biopsy that's already standard with PGT-A.

1

Pre-screen call

Complimentary 30-minute call with a genetic counselor.

Before cycle

2

Embryo biopsy

~5 cells per embryo.

During IVF

3

Sequencing

Orchid's CAP/CLIA lab.

4 weeks

4

Results review

Counselor walks you through.

Before transfer

Patient stories

Why families come to us.

Eventbrite co-founders Kevin and Julia Hartz chose Orchid's whole-genome screening to understand each embryo at depth before transfer. In journalist Ashlee Vance's Core Memory feature, Kevin explains why.

Watch full video
Core Memory
“Any way to mitigate those [diseases] is really a no-brainer.”

Kevin Hartz · Co-founder, Eventbrite

Kevin and Julia Hartz

Kevin & Julia Hartz

Co-founders, Eventbrite · Orchid customers

“Orchid gave us clarity around the things that we care about, especially our family history of conditions. We move forward now with so much more confidence than we would have.”

Common questions.

Pulled from the actual questions our counselors hear most weeks.

The biopsy is performed on the placenta-side of the embryo on day 5 or 6 and has been used in IVF for over a decade. Studies show no measurable effect on pregnancy or live-birth rates.

Talk it through with a counselor.

Free 30-minute consult. A genetic counselor walks you through your options and answers your specific questions. No pressure, no commitment to test.

Free · No obligation · HIPAA compliant

Enter a 10-digit US phone number in the format (555) 123-4567.

By submitting, you agree to be contacted by Orchid. We never share your info. You can opt out any time.

© 2026 Orchid Health · CAP & CLIA certified · HIPAA compliant

PrivacyTermsFull site →